Stock listing

NASDAQ:ANL Adlai Nortye Group Ltd. Stock

Follow Adlai Nortye Group Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:ANL

$8.55 USD -0.19 (-2.2%)

Close on Nov 20, 2026

Past year +497.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$8.36 – $9.11 USDNov 20, 2026
Volume
380,645 sharesNov 20, 2026
Market cap
$502.2M USDAt the close on Nov 20, 2026 · price × 58.73M shares outstanding
52-week range
$0.879 – $17.25 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3.02M USDMedian day 171,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Adlai Nortye Group Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ANL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$8.55-0.19-2.2%$8.93$9.11$8.36380,645
$8.74-0.74-7.8%$9.45$9.64$8.52454,919
$9.48-0.55-5.5%$9.99$9.99$9.375291,789
$10.03-0.58-5.5%$10.60$11.00$9.79172,076
$10.61+0.09+0.9%$10.52$10.84$9.91152,056
$10.52-0.33-3.0%$10.62$10.79$10.22130,644
$10.85+0.89+8.9%$10.03$11.21$9.76195,930
$9.96-1.19-10.7%$10.98$11.15$9.46377,005
$11.15+0.87+8.5%$9.85$11.45$9.85263,352
$10.28+0.60+6.2%$9.77$10.64$9.43531,007
$9.68+0.07+0.7%$9.61$9.85$8.90450,319
$9.61+0.03+0.3%$9.70$10.06$9.075238,622
$9.58+0.21+2.2%$9.39$9.925$9.39236,053
$9.37-0.18-1.9%$9.75$9.89$9.21272,626
$9.55-0.73-7.1%$10.11$10.13$9.36262,097
$10.28+0.08+0.8%$10.20$10.68$10.2044,559
$10.20-0.51-4.8%$11.10$11.10$10.04125,334
$10.71+0.13+1.2%$10.68$11.10$10.6871,157
$10.580.000.0%$10.71$10.85$10.52132,919
$10.580.000.0%$10.55$10.65$10.3079,500
$10.58-0.68-6.0%$11.01$11.22$10.58170,000
$11.26+0.62+5.8%$10.80$11.68$10.80532,600
$10.64+0.26+2.5%$10.37$11.32$10.37242,600
$10.38-0.65-5.9%$10.97$11.38$10.34356,500
$11.03-1.06-8.8%$11.89$12.04$10.93336,600
$12.09+1.21+11.1%$11.23$12.46$11.23864,200
$10.88-0.875-7.4%$11.88$12.11$10.80378,000
$11.76-2.465-17.3%$14.20$14.20$11.40957,700
$14.22-1.40-9.0%$15.65$16.22$13.91415,700
$15.62+0.11+0.7%$15.33$16.74$14.87300,400
$15.51+1.46+10.4%$13.87$16.05$13.78985,300
$14.05-0.41-2.8%$14.41$15.04$14.0395,100
$14.46-0.58-3.9%$15.03$15.68$14.2399,800
$15.04-0.05-0.3%$14.80$15.82$14.34460,600
$15.09-0.67-4.3%$15.76$15.80$14.8377,000
$15.76-0.24-1.5%$16.00$16.20$15.54124,800
$16.00+0.35+2.2%$15.87$16.31$15.5093,900
$15.65+0.25+1.6%$15.26$15.82$15.1163,000
$15.40-0.13-0.8%$15.70$15.86$15.1063,500
$15.53-0.30-1.9%$16.16$16.16$15.3834,800
$15.83+0.08+0.5%$15.51$16.05$14.70144,300
$15.75-0.85-5.1%$16.47$16.95$15.60218,100
$16.60+1.03+6.6%$15.80$16.73$15.66105,200
$15.57-0.17-1.1%$15.99$16.16$15.0592,600
$15.74+0.46+3.0%$15.13$15.92$15.13156,600
$15.28-0.24-1.5%$15.89$16.25$15.0091,500
$15.52+0.52+3.5%$15.16$15.75$14.93220,800
$15.00-0.93-5.8%$15.92$16.19$14.87171,300
$15.93+0.72+4.7%$15.18$16.10$15.13175,600
$15.21+0.12+0.8%$15.32$16.00$15.20228,700
$15.09+0.395+2.7%$14.97$15.78$14.70318,200
$14.70-0.815-5.3%$15.44$15.94$14.42161,800
$15.51+0.50+3.3%$15.12$16.12$14.82405,000
$15.01+0.26+1.8%$14.69$16.02$14.55308,600
$14.75+0.895+6.5%$13.95$14.79$13.7877,000
$13.86+0.225+1.7%$13.76$14.20$13.4877,700
$13.63-0.56-3.9%$14.02$14.41$13.32104,400
$14.19+0.37+2.7%$13.84$14.44$13.26139,200
$13.82-0.50-3.5%$14.41$14.46$13.53165,000
$14.32-0.74-4.9%$14.88$15.20$14.05137,000
$15.06+1.32+9.6%$13.70$15.11$13.50147,800
$13.74-0.42-3.0%$14.09$14.29$13.55100,200
$14.16+0.46+3.4%$13.66$14.40$13.14185,800
$13.70-0.02-0.1%$13.97$14.28$13.52103,100
$13.72-0.61-4.3%$14.30$14.30$13.56117,200
Ticker
NASDAQ:ANL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Adlai Nortye Group Ltd. news

Adlai Nortye Group Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Oct 27, 2026 · oldest 2026
Decks
4 decks · latest September 2026

Valuation

EV/sales 59.4× against a median of 13.1×: the highest of 6 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$297.0M USD
P/E
Loss
EV/sales
59.4×
EV/EBITDA
Negative EBITDA
Price/book
2.3×
Gross margin
100.0%
Operating margin
−714.0%
Net margin
−710.6%
Debt to equity
0.1×
Beta vs S&P 500
1.96

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Adlai Nortye Group Ltd. · NASDAQ:ANLUS$502.2MUS$297.0Mn/a59.4×n/a2.3×−710.6%0.1×1.96
Abbisko Cayman Limited · HKEX:2256US$518.9MUS$228.0Mn/an/an/a1.6×n/a0.2×n/a
Alumis Inc. · NASDAQ:ALMSUS$512.6MUS$116.5Mn/a16.1×n/a1.4×n/a0.1×1.58
Electra Therapeutics, Inc. · NASDAQ:ETRAUS$509.8MUS$107.3Mn/an/an/a1.3×n/a0.0×n/a
Wave Life Sciences Ltd. · NASDAQ:WVEUS$504.9MUS$74.16Mn/a1.1×n/a1.3×−296.9%0.0×1.70
Steminent Biotherapeutics, Inc. · TPEX:7729US$496.9MUS$470.4Mn/an/an/a16.2×n/a0.0×n/a
Xuanzhu Biopharmaceutical Co., Ltd. Class H · HKEX:2575US$495.2MUS$407.1Mn/a23.2×n/a2.2×−200.8%0.0×n/a
TenNor Therapeutics Suzhou Ltd. Class H · HKEX:6872US$489.2MUS$391.6Mn/an/an/a5.0×n/a0.1×n/a
Crescent Biopharma, Inc. · NASDAQ:CBIOUS$482.9MUS$196.0Mn/a13.1×n/a1.8×−727.6%0.0×0.92
Sana Biotechnology, Inc. · NASDAQ:SANAUS$476.4MUS$408.5Mn/an/an/a2.6×n/a0.3×2.29
Regenxbio Inc. · NASDAQ:RGNXUS$473.4MUS$289.0Mn/a1.9×n/a3.2×−113.9%0.5×1.60
Median of the othersUS$496.1MUS$258.5M13.1×2.0×−248.8%0.1×1.60

Forecasts

7 strong buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
29.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.18 · 7 analysts
Revenue, year to Dec 2026
17.19M · 7 analysts

Team and board

Officers

OfficerRole
Yang LuCEO, Chairman of the Board of Directors
Xiaofeng YeChief Financial Officer
Archie TsePresident, Head of R&D
Christopher LiuHead of Investor Relations and Public Relations
Nanhai HeHead of Discovery
Zhiyong YuHead of Operation

Board

DirectorRole
Yang LuCEO, Chairman of the Board of Directors
Baozhong WeiIndependent Director
Lars E. BirgersonDirector
Ming Lun Alan TseIndependent Director
Ping JiDirector
Roger SawhneyIndependent Director
Shaorong LiuIndependent Director

Events

QuarterResultsShare move
Q4 2025Feb 25, 2026−9.2%
Q3 2025Dec 3, 2025−17.2%
Q2 2025Aug 7, 2025+0.7%
Q1 2025Apr 30, 2025+1.0%
Q3 2024Nov 27, 2024+2.8%
Q2 2024Aug 8, 2024+6.7%
Q4 2023Feb 28, 20240.0%
Q3 2023Nov 29, 2023+4.1%
Q2 2023Aug 30, 2023

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck43 slidesSeptember 2026
Investor Presentation (April 2026)Investor deck30 slidesApr 16, 2026
AACR-NCI-EORTC 2025Conference11 slidesOct 25, 2025
Investor Presentation (May 2024)Investor deck31 slidesMay 24, 2024

Open Decks

IPO

Went public as Adlai Nortye Ltd. Priced at US$23.00 an ADS on Sep 29, 2023.

Price
US$23.00 an ADS
ADSs offered
2,500,000 American depositary shares
Offering size
US$57.5 million
Listing
ANL on the Nasdaq Global Market
Underwriter
Cantor
ADSs delivered
On or about Oct 3, 2023

Steps

StepWhen
Draft sent to the SEC in confidenceDec 21, 2022
Filed publiclyJul 27, 2023
Amended 4 timesNewest Sep 27, 2023
Shares registered with an exchangeAug 7, 2023
Declared effective by the SECSep 28, 2023
Final prospectus, with the priceSep 29, 2023

Filings

FilingFiled
424B4 · ProspectusSep 29, 2023
EFFECT · Notice that a registration is effectiveSep 28, 2023
CERT · Exchange's certificate of listingSep 28, 2023
CORRESP · Letter to the SECSep 27, 2023
CORRESP · Letter to the SECSep 27, 2023
CORRESP · Letter to the SECSep 27, 2023
F-1/A · Registration statement, amendedSep 27, 2023
UPLOAD · Letter from the SECSep 20, 2023
CORRESP · Letter to the SECSep 12, 2023
F-1/A · Registration statement, amendedSep 12, 2023
All 34 filings
FilingFiled
8-A12B · Registration of shares for listing on an exchangeAug 18, 2023
UPLOAD · Letter from the SECAug 16, 2023
CORRESP · Letter to the SECAug 14, 2023
F-1/A · Registration statement, amendedAug 14, 2023
CORRESP · Letter to the SECAug 10, 2023
F-1/A · Registration statement, amendedAug 10, 2023
8-A12B · Registration of shares for listing on an exchangeAug 7, 2023
CORRESP · Letter to the SECJul 27, 2023
F-1 · Registration statementJul 27, 2023
UPLOAD · Letter from the SECJun 29, 2023
DRSLTR · Letter to the SEC with a draftJun 22, 2023
DRS/A · Draft registration statement, amendedJun 22, 2023
UPLOAD · Letter from the SECMay 19, 2023
DRSLTR · Letter to the SEC with a draftMay 11, 2023
DRS/A · Draft registration statement, amendedMay 11, 2023
UPLOAD · Letter from the SECApr 27, 2023
DRSLTR · Letter to the SEC with a draftApr 14, 2023
DRS/A · Draft registration statement, amendedApr 14, 2023
UPLOAD · Letter from the SECMar 13, 2023
DRSLTR · Letter to the SEC with a draftFeb 27, 2023
DRS/A · Draft registration statement, amendedFeb 27, 2023
UPLOAD · Letter from the SECJan 18, 2023
DRSLTR · Letter to the SEC with a draftDec 21, 2022
DRS · Draft registration statementDec 21, 2022

Open IPO · From the cover of the final prospectus (424B4) filed Sep 29, 2023

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue5.00M05.00M045.7M
Cost of revenue1.87M2.22M2.04M1.51M1.48M
Gross profit5.00M-1.87M5.00M-2.04M45.7M-1.51M-1.48M
Research and development32.8M44.9M58.2M54.5M42.1M19.0M13.3M
Selling, general and administrative7.79M9.44M14.8M12.4M12.4M6.52M
Operating income-35.7M-52.9M-72.6M-67.3M-8.65M-26.1M-19.1M
Depreciation and amortization1.41M510.0K465.0K609.0K861.0K1.51M1.48M
EBITDA-34.3M-52.4M-72.1M-66.7M-7.79M-24.6M-17.6M
Interest expense1.49M1.94M791.0K433.0K1.34M1.75M466.1K
Income before tax-35.5M-51.9M-109.2M-58.8M-56.7M-63.4M-17.8M
Income tax643.0K8.31M-46.2M3-1
Net income-35.5M-51.9M-109.2M-58.8M-56.7M-63.4M-17.8M
Earnings per share, basic-3.33-0.54-2.52-2.31-2.23-7.47-2.10
Earnings per share, diluted-0.54-2.52-2.31-2.23

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents23.8M60.9M91.5M42.8M64.1M24.2M6.02M
Short-term investments07.00K7.01M21.3M53.8M241.0K
Receivables1.39M1.17M359.0K346.0K1.93M394.0K91.6K
Inventory1-310011
Current assets26.9M64.1M101.2M66.3M124.5M28.6M6.43M
Property, plant and equipment1.74M2.65M3.71M3.65M
Total assets34.4M71.3M130.2M72.6M131.7M36.7M10.8M
Accounts payable12.6M10.1M14.3M13.1M2.98M1.53M5.26M
Current liabilities41.6M45.4M49.7M312.7M17.5M88.0M20.3M
Total debt26.4M26.3M30.4M4.31M10.5M11.0M11.9M
Total liabilities42.8M45.8M55.1M313.9M317.1M168.3M80.2M
Shareholders' equity-8.32M25.5M75.0M-241.3M-185.4M-131.6M-69.4M
Shares outstanding10.7M10.6M6.80M40.4M12.3M8.48M8.48M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-33.5M-51.8M-56.7M-43.2M-3.03M-34.6M-14.9M
Capital spending-187.5K-170.0K-200.0K-1.25M-1.02M-1.62M-185.0K
Free cash flow-33.7M-52.0M-56.9M-44.5M-4.05M-36.2M-15.1M
Cash from investing-15.6M28.1M-11.0M28.4M-54.9M-1.61M-184.5K
Cash from financing-3.82M-6.58M116.2M-6.78M97.2M53.9M16.2M
Dividends paid00000
Change in cash-37.1M-30.3M48.6M-21.6M39.3M18.2M1.11M

Open Financials

Filings

FilingDateTypeFiled with
6-K · Report of a foreign issuerOct 28, 2026Current reportSEC
6-K · Report of a foreign issuerOct 15, 2026Current reportSEC
4 · Change in ownershipOct 1, 2026Insider tradeSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
6-K · Report of a foreign issuerSep 30, 2026Current reportSEC
4 · Change in ownershipSep 24, 2026Insider tradeSEC
144 · Notice of proposed saleSep 18, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 16, 2026Other filingsSEC
S-8 POSSep 11, 2026Offer documentSEC
S-8 POSSep 11, 2026Offer documentSEC
All 114 filings
FilingDateTypeFiled with
POS AM · Amendment to an effective registrationSep 11, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 8, 2026Current reportSEC
4 · Change in ownershipAug 26, 2026Insider tradeSEC
6-K · Report of a foreign issuerAug 26, 2026Current reportSEC
6-K · Report of a foreign issuerAug 19, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerAug 14, 2026Current reportSEC
3 · Initial statement of ownershipAug 4, 2026Insider tradeSEC
6-K · Report of a foreign issuerAug 3, 2026Current reportSEC
424B7 · ProspectusJul 20, 2026Offer documentSEC
6-K · Report of a foreign issuerJul 16, 2026Current reportSEC
3 · Initial statement of ownershipJul 15, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 1, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 28, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 21, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 20, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2026Big-stake noticeSEC
3/A · Initial statement of ownership, amendedMay 14, 2026Insider tradeSEC
3/A · Initial statement of ownership, amendedMay 8, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 8, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 29, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveApr 29, 2026Other filingsSEC
CORRESP · Letter to the SECApr 24, 2026Other filingsSEC
F-3/A · Registration statement, amendedApr 24, 2026Offer documentSEC
F-3/A · Registration statement, amendedApr 23, 2026Offer documentSEC
6-K · Report of a foreign issuerApr 16, 2026Current reportSEC
20-F · Annual reportApr 10, 2026Annual reportSEC
6-K · Report of a foreign issuerApr 1, 2026Current reportSEC
UPLOAD · Letter from the SECMar 10, 2026Other filingsSEC
F-3 · Registration statementMar 10, 2026Offer documentSEC
6-K · Report of a foreign issuerFeb 12, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeFeb 11, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 9, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerFeb 3, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 20, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJan 16, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerDec 29, 2025Current reportSEC
6-K · Report of a foreign issuerDec 29, 2025Current reportSEC
6-K · Report of a foreign issuerDec 3, 2025Current reportSEC
6-K · Report of a foreign issuerOct 22, 2025Current reportSEC
S-8 · Registration statement for employee plansSep 15, 2025Offer documentSEC
6-K · Report of a foreign issuerJul 9, 2025Current reportSEC
6-K · Report of a foreign issuerMay 30, 2025Current reportSEC
20-F/A · Annual report, amendedMay 9, 2025Annual reportSEC
20-F · Annual reportApr 30, 2025Annual reportSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 27, 2025Other filingsSEC
20-F/A · Annual report, amendedFeb 14, 2025Annual reportSEC
6-K · Report of a foreign issuerFeb 14, 2025Current reportSEC
CORRESP · Letter to the SECJan 27, 2025Other filingsSEC
CORRESP · Letter to the SECJan 2, 2025Other filingsSEC
6-K · Report of a foreign issuerDec 31, 2024Current reportSEC
UPLOAD · Letter from the SECDec 18, 2024Other filingsSEC
6-K · Report of a foreign issuerAug 8, 2024Current reportSEC
6-K · Report of a foreign issuerJul 3, 2024Current reportSEC
6-K · Report of a foreign issuerJun 27, 2024Current reportSEC
6-K · Report of a foreign issuerMay 23, 2024Current reportSEC
S-8 · Registration statement for employee plansMay 13, 2024Offer documentSEC
20-F · Annual reportApr 19, 2024Annual reportSEC
6-K · Report of a foreign issuerApr 2, 2024Current reportSEC
SC 13G · Big-stake noticeMar 4, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 15, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 15, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 31, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeOct 13, 2023Big-stake noticeSEC
424B4 · ProspectusSep 29, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 29, 2023Other filingsSEC
CERT · Exchange's certificate of listingSep 28, 2023Other filingsSEC
CORRESP · Letter to the SECSep 27, 2023Other filingsSEC
CORRESP · Letter to the SECSep 27, 2023Other filingsSEC
CORRESP · Letter to the SECSep 27, 2023Other filingsSEC
F-1/A · Registration statement, amendedSep 27, 2023Offer documentSEC
UPLOAD · Letter from the SECSep 20, 2023Other filingsSEC
CORRESP · Letter to the SECSep 12, 2023Other filingsSEC
F-1/A · Registration statement, amendedSep 12, 2023Offer documentSEC
8-A12B · Registration of shares for listing on an exchangeAug 18, 2023Other filingsSEC
UPLOAD · Letter from the SECAug 16, 2023Other filingsSEC
CORRESP · Letter to the SECAug 14, 2023Other filingsSEC
F-1/A · Registration statement, amendedAug 14, 2023Offer documentSEC
CORRESP · Letter to the SECAug 10, 2023Other filingsSEC
F-1/A · Registration statement, amendedAug 10, 2023Offer documentSEC
8-A12B · Registration of shares for listing on an exchangeAug 7, 2023Other filingsSEC
CORRESP · Letter to the SECJul 27, 2023Other filingsSEC
F-1 · Registration statementJul 27, 2023Offer documentSEC
UPLOAD · Letter from the SECJun 29, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftJun 22, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedJun 22, 2023Offer documentSEC
UPLOAD · Letter from the SECMay 19, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftMay 11, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedMay 11, 2023Offer documentSEC
UPLOAD · Letter from the SECApr 27, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftApr 14, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedApr 14, 2023Offer documentSEC
UPLOAD · Letter from the SECMar 13, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftFeb 27, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedFeb 27, 2023Offer documentSEC
UPLOAD · Letter from the SECJan 18, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftDec 21, 2022Other filingsSEC
DRS · Draft registration statementDec 21, 2022Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Adlai Nortye Group Ltd.’s releases

Common shares
58,734,603
Fully diluted
58,734,603

Fully diluted

LineShares
Common shares58,734,603

Share count over time

CountShares
Nov 22, 202658,734,603

Open Cap table

Shareholders

HolderSharesOf the companyValueChange vs Jun 30Filed
Cormorant Asset Management, LP3.98M6.8%US$63.7MNewNov 16, 2026
Ameriprise3.31M5.6%US$53MNewNov 16, 2026
Venrock Adviser, LLC3.21M5.5%US$51.4MNewNov 16, 2026
Balyasny Asset Management L.P.2.7M4.6%US$43.1MNewNov 16, 2026
Point72 Asset Management, L.P.2.15M3.7%US$34.4MNewNov 16, 2026
Mpm Bioimpact LLC1.96M3.3%US$31.3MNewNov 16, 2026
Perceptive Advisors LLC1.66M2.8%US$26.6MNewNov 16, 2026
Soleus Capital Management, L.P.1.27M2.2%US$20.4MNewNov 16, 2026
Casdin Capital, LLC1.25M2.1%US$20MNewNov 16, 2026
Eventide Asset Management, LLC1.07M1.8%US$17.1MNewNov 13, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
ADAR1 Capital Management, LLC997K1.7%US$16MNewNov 16, 2026
Millennium971K1.7%US$15.5MNewNov 16, 2026
Octagon Capital Advisors LP935K1.6%US$15MNewNov 16, 2026
Braidwell LP795K1.4%US$12.7MNewNov 16, 2026
Squadron Capital Management LLC765K1.3%US$12.2MNewNov 16, 2026
Adage Capital Partners Gp, L.L.C.638K1.1%US$10.2MNewNov 16, 2026
Superstring Capital Management LP588K1.0%US$9.41MNewNov 16, 2026
Woodline Partners LP456K0.78%US$7.29MNewNov 16, 2026
Boone Capital Management LLC258K0.44%US$4.13MNewNov 16, 2026
Sphera Funds Management LTD.236K0.40%US$3.77MNewNov 16, 2026
DAFNA Capital Management LLC233K0.40%US$3.72MNewNov 16, 2026
Silverarc Capital Management, LLC217K0.37%US$3.47MNewNov 12, 2026
Freestone Grove Partners LP189K0.32%US$3.02MNewNov 16, 2026
UBS159K0.27%US$2.55MNewNov 10, 2026
Affinity Asset Advisors, LLC154K0.26%US$2.46MNewNov 13, 2026
Palo Alto Investors LP149K0.25%US$2.39MNewNov 16, 2026
ExodusPoint Capital Management, LP133K0.23%US$2.13MNewNov 16, 2026
Seven Fleet Capital Management LP116K0.20%US$1.86MNewNov 16, 2026
Moore Capital Management, LP90,2340.15%US$1.44MNewNov 16, 2026
Marshall Wace, LLP76,2100.13%US$1.22MNewNov 13, 2026
Tidal Investments LLC75,2830.13%US$1.2MNewNov 13, 2026
Renaissance Technologies61,5970.10%US$986KNewNov 12, 2026
JPMorgan57,0690.10%US$893KNewNov 12, 2026
Bank of America52,4260.09%US$839KNewNov 16, 2026
Morgan Stanley42,1930.07%US$675KNewNov 13, 2026
State Street36,2000.06%US$579KNewNov 12, 2026
Walleye Capital LLC36,0230.06%US$576KNewNov 13, 2026
Verition Fund Management LLC33,9960.06%US$544KNewNov 13, 2026
Ikarian Capital, LLC33,8990.06%US$542KNewNov 16, 2026
Goldman Sachs31,6290.05%US$506KNewNov 16, 2026
Virtus Investment Advisers, LLC30,7490.05%US$492KNewNov 12, 2026
ACT Capital Partners, L.P.24,4000.04%US$430KFirst reportNov 6, 2026
Geode Capital17,0200.03%US$272KNewNov 6, 2026
Hrt Financial LP13,1140.02%US$209KNewNov 13, 2026
Mangrove Partners Im, LLC11,5550.02%US$185KNewNov 16, 2026
BlackRock8,0240.01%US$128KNewNov 13, 2026
BNP Paribas3,840<0.01%US$61,440NewNov 12, 2026
ANTIPODES PARTNERS Ltd1,808<0.01%US$28,928NewNov 4, 2026
China Universal Asset Management Co., Ltd.1,600<0.01%US$25,040NewOct 27, 2026
Picton Mahoney Asset Management147<0.01%US$2,352NewNov 9, 2026

This page holds 50 of 52 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Roger Sawhney
Other companies: Arbutus Biopharma Corporation (Director · Since at least Aug 4, 2025); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Alimera Sciences Inc (Director · Feb 25, 2023 – Feb 25, 2023 · Past); Omega Therapeutics Inc (Chief Financial Officer · Jul 29, 2021 – Mar 9, 2022 · Past)
Independent Director · Since at least Mar 18, 2026
Alan Ming Lun TseDirector · Since at least Mar 18, 2026
Archie TsePresident, Head of R&D · Since at least Mar 18, 2026
Baozhong WeiIndependent Director · Since at least Nov 5, 2026
Christopher LiuHead of Investor Relations and Public Relations · Since at least Nov 5, 2026
Kaiyang TangPresident, Adlai Nortye USA · Since at least Mar 18, 2026
Lars E. BirgersonDirector · Since at least Mar 18, 2026
Ming Lun Alan TseIndependent Director · Since at least Nov 5, 2026
Nanhai HeHead of Discovery · Since at least Nov 5, 2026
Ping JiDirector · Since at least Mar 18, 2026
All 14 people
PersonSeat
Shaorong LiuIndependent Director · Since at least Nov 5, 2026
Xiaofeng YeCFO · Since at least May 28, 2026
Yang LuCEO, Director · Since at least Mar 18, 2026
Zhiyong YuHead of Operation · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Adlai Nortye Group Ltd.